Supplementary Tables – Frontline anti-PD-1/PD-L1 versus bevacizumab in advanced non-small cell lung cancer: a network meta-analysis
收藏数据链接：
官方服务：
资源简介：
Supplementary Table S1–S4. Frontline anti-PD-1/PD-L1 versus bevacizumab in advanced non-small cell lung cancer: a network meta-analysis
创建时间：
2022-02-07
